Apella Capital, LLC Abbott Laboratories Transaction History

Apella Capital, LLC

$2.54 Billion
Q4 2024

A detailed history of Apella Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Apella Capital, LLC holds 6,371 shares of ABT stock, worth $816,889. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,371

Previous 6,191 2.91%

Holding current value

$816,889

Previous $705,000 2.13%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$111.93 - $119.39 $20,147 - $21,490	180 Added 2.91%	6,371 $720,000
Q3 2024 Oct 03, 2024	BUY	$100.07 - $118.13 $18,512 - $21,854	185 Added 3.08%	6,191 $705,000
Q2 2024 Jul 10, 2024	SELL	$100.73 - $112.44 $5,137 - $5,734	-51 Reduced 0.84%	6,006 $624,000
Q1 2024 Apr 10, 2024	SELL	$109.52 - $120.96 $7,447 - $8,225	-68 Reduced 1.11%	6,057 $688,000
Q4 2023 Jan 05, 2024	SELL	$90.19 - $110.4 $17,226 - $21,086	-191 Reduced 3.02%	6,125 $674,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $12,514 - $15,015	-131 Reduced 2.03%	6,316 $611,000
Q2 2023 Jul 06, 2023	SELL	$100.78 - $112.29 $175,155 - $195,160	-1,738 Reduced 21.23%	6,447 $702,000
Q4 2022 Jan 10, 2023	SELL	$95.06 - $111.52 $32,510 - $38,139	-342 Reduced 4.01%	8,185 $0
Q3 2022 Oct 11, 2022	BUY	$96.76 - $112.03 $106,726 - $123,569	1,103 Added 14.86%	8,527 $825,000
Q2 2022 Jul 08, 2022	BUY	$102.07 - $123.37 $25,313 - $30,595	248 Added 3.46%	7,424 $807,000
Q1 2022 Apr 11, 2022	BUY	$114.02 - $139.04 $220,400 - $268,764	1,933 Added 36.87%	7,176 $849,000
Q4 2021 Jan 13, 2022	SELL	$115.53 - $141.46 $1,964 - $2,404	-17 Reduced 0.32%	5,243 $738,000
Q3 2021 Jan 18, 2022	SELL	$116.66 - $129.06 $22,282 - $24,650	-191 Reduced 3.5%	5,260 $621,000
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $24,965 - $27,618	214 Added 4.09%	5,451 $632,000
Q2 2021 Jan 18, 2022	SELL	$105.79 - $124.53 $20,946 - $24,656	-198 Reduced 3.64%	5,237 $607,000
Q2 2021 Jul 02, 2021	BUY	$105.79 - $124.53 $53,529 - $63,012	506 Added 10.27%	5,435 $630,000
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $309,639 - $452,777	4,929 New	4,929 $389,000

Others Institutions Holding ABT

# of Institutions

3,244

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.03M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.

Account

Apella Capital, LLC Abbott Laboratories Transaction History